{
    "code": "01039059",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01039059",
    "time": "2020-02-25 06:23:50",
    "許可證字號": "衛署藥製字第039059號",
    "註銷狀態": "已註銷",
    "註銷日期": "104\/07\/16",
    "註銷理由": "自請註銷",
    "有效日期": "104\/07\/19",
    "發證日期": "84\/07\/19",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00103905907",
    "中文品名": "&quot;永勝&quot;達樂腸溶錠５毫克（鋸齒酵素）",
    "英文品名": "DANLASE E.C TABLETS 5MG (SEEATIOPEPTICASE) &quot;EVEREST&quot;",
    "適應症": "手術後以及外傷後之消炎、副鼻腔炎、膀胱炎、副睪丸炎、智齒周圍炎、齒槽膿瘍之消炎、支氣管炎、支氣管氣喘引起之喀痰果難麻醉後引起之喀痰困難",
    "劑型": "115腸溶錠",
    "包裝": "6-1000粒鋁箔盒裝 6-1000粒、2000粒塑膠瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "01國　產",
        "申請商名稱": "0502918200  永勝藥品工業股份有限公司",
        "申請商地址": "嘉義縣民雄鄉興南村頭橋工業區工業三路６之３號",
        "主製造廠": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2808403400",
            "成分名稱": "SERRAPEPTASE (SERRATIOPEPTIDASE)",
            "含量描述": "5",
            "含量": "5.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "010390590001.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01039059&Seq=001&Type=9"
        },
        {
            "title": "010390590003.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01039059&Seq=003&Type=8"
        }
    ]
}